Rapidly progressive interstitial lung disease-associated hypomyopathic dermatomyositis complicated with pneumomediastinum: A case-based review

Translated title of the contribution: Rapidly progressive interstitial lung disease-associated hypomyopathic dermatomyositis complicated with pneumomediastinum: A case-based review

Julio Alejandro Cerna-López, Paul J. Tejada-Llacsa, Fiorella Andrea de Jesús Valle-Farfán, Graciela S. Alarcón, Manuel F. Ugarte-Gil, Víctor R. Pimentel-Quiroz

Research output: Contribution to journalArticlepeer-review

Abstract

Clinically amyopathic dermatomyositis (CADM) is associated with antibodies directed against the protein encoded by the melanoma differentiation-associated gene 5 (MDA5). CADM patients have an increased risk of developing rapidly progressive interstitial lung disease (RP-ILD) and spontaneous pneumomediastinum. Two Peruvian cases of RP-ILD-associated CADM with spontaneous pneumomediastinum are presented, one of them was anti-MDA5 antibody positive. To our knowledge, this is the first report of anti-MDA5-associated CADM in the Peruvian population.

Translated title of the contributionRapidly progressive interstitial lung disease-associated hypomyopathic dermatomyositis complicated with pneumomediastinum: A case-based review
Original languageEnglish
Pages (from-to)277-282
Number of pages6
JournalRevista Colombiana de Reumatologia
Volume30
Issue number3
DOIs
StatePublished - 1 Jul 2023

Keywords

  • Anti-MDA5 antibodies
  • Clinically amyopathic dermatomyositis
  • Spontaneous pneumomediastinum

Fingerprint

Dive into the research topics of 'Rapidly progressive interstitial lung disease-associated hypomyopathic dermatomyositis complicated with pneumomediastinum: A case-based review'. Together they form a unique fingerprint.

Cite this